People · Operator

Christa J. Kreuzburg

Named in public records as an officer, director or promoter · active 2019–2019 · Pharmaceuticals

1
Companies
1
Filings
$650.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Catalent, Inc.PharmaceuticalsGrowth/Late$650.0M$23.6B2019
Operator network

Christa J. Kreuzburg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Gregory T. Lucier · 4 companies · 1 sharedGregory T. LucierJ. Martin Carroll · 2 companies · 1 sharedJ. Martin CarrollRolf A. Classon · 2 companies · 1 sharedRolf A. ClassonRosemary A. Crane · 2 companies · 1 sharedRosemary A. CraneAlessandro E. Maselli · 1 companies · 1 sharedAlessandro E. Mas…Donald E. Morel Jr. · 1 companies · 1 sharedDonald E. Morel J…Jack L. Stahl · 1 companies · 1 sharedJack L. StahlJohn J. Greisch · 1 companies · 1 sharedJohn J. GreischJohn R. Chiminski · 1 companies · 1 sharedJohn R. ChiminskiMadhavan L. Balachandran · 1 companies · 1 sharedMadhavan L. Balac…Peter E. Zippelius · 1 companies · 1 sharedPeter E. ZippeliusSteven L. Fasman · 1 companies · 1 sharedSteven L. FasmanWetteny E. Joseph · 1 companies · 1 sharedWetteny E. JosephCatalent, Inc. · $650.0M raisedCatalent, Inc.Christa J. KreuzburgCK
Christa J. Kreuzburg Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Christa J. Kreuzburg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Gregory T. Lucier14
J. Martin Carroll12
Rosemary A. Crane12
Rolf A. Classon12
Madhavan L. Balachandran11
Steven L. Fasman11
John R. Chiminski11
John J. Greisch11
Donald E. Morel Jr.11
Peter E. Zippelius11
Wetteny E. Joseph11
Alessandro E. Maselli11
Jack L. Stahl11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.